Brief: Adc Therapeutics Q4 Cash And Cash Equivalents Were $466.5 Mln
03/03/2022 13:05
March 3 (Reuters) - ADC Therapeutics SA ADCT.N :
* CASH AND CASH EQUIVALENTS WERE $466.5 MILLION AS OF
DECEMBER 31,
2021, COMPARED TO $439.2 MILLION AS OF DECEMBER 31, 2020
Source text for Eikon: ID:nBw9KvNJCa
Further company coverage: ADCT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adc Therapeutics
See all newsBrief: Adc Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
ADC Therapeutics SA reports results for the quarter ended June 30 - Earnings Summary
ADC Therapeutics Q2 loss narrows; cuts 17% workforce
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview